Viracta Therapeutics, Inc. — Revenue by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6dac3e4e-c3f8-4dc5-8e48-2f0cd4d8c9a8/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2020 | $120.0k | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-007784 |
| FY 2019 | $2.1M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-009783 |
| FY 2018 | $237.0k | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006828 |
| FY 2017 | $669.0k | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-006828 |
| FY 2016 | $2.5M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-003862 |
| FY 2015 | $3.1M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014612 |
| FY 2014 | $5.7M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001589 |
| FY 2013 | $8.0M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-086649 |
| FY 2012 | $3.8M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-105232 |
| FY 2011 | $5.0M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-114990 |
| FY 2010 | $33.0k | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-114990 |
| FY 2009 | $3.8M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-114990 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Viracta Therapeutics, Inc. — all facts · Net Income · Operating Income